PHI with Martorell syndrome
How does this condition affect your private health insurance?
Martorell's syndrome, also known as obliterative subclavian arteritis or chronic subclavian occlusion, is a rare vascular condition characterized by progressive occlusion of the subclavian artery. This chronic process severely restricts blood flow to the arm, hand, and fingers, often leading to critical limb ischemia. Symptoms can include pain, pallor, paresthesia, and pulselessness in the affected limb, potentially progressing to digital gangrene and tissue loss. It's frequently associated with atherosclerosis, smoking, and diabetes. Early diagnosis and revascularization are crucial to prevent severe complications and preserve limb function.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several weeks to months for significant symptom manifestation leading to diagnosis and intervention.
Duration of Illness (Lifetime)
Chronic, progressive disease over many years, often life-long requiring ongoing management.
Cost of Treatment (Initial)
High, ranging from tens of thousands to hundreds of thousands of dollars for diagnostics (e.g., angiography) and initial revascularization procedures (e.g., stenting, bypass surgery).
Cost of Treatment (Lifetime)
Very high, accumulating to several hundred thousand dollars due to potential repeat interventions, lifelong medication, rehabilitation, and management of chronic complications like wound care or amputations.
Mortality Rate
Low directly, but significantly increased risk (10-20% over 5 years) of cardiovascular morbidity and mortality due to underlying systemic atherosclerosis and potential severe complications like infection from gangrene.
Risk of Secondary Damages
High (70-90%) for chronic pain, functional impairment, digital gangrene, and potential limb amputation if left untreated or poorly managed. Psychological impact is also significant.
Probability of Full Recovery
Low (less than 20%) for complete recovery without any long-term consequences; revascularization improves symptoms but the underlying pathology (e.g., atherosclerosis) often persists, requiring ongoing management.
Underlying Disease Risk
Very high (over 80-90%) for underlying systemic atherosclerosis, hypertension, diabetes mellitus, hyperlipidemia, and a strong association with smoking.